Physician profile
Andre K Gabriel
NPI 1629506779
$17,091.45
in general payments reported to CMS, 2019-2025
23 companies · $1,885 in 2025
The $1,885 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $15K · 2025: $1,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $3,835 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,102.18 |
| Food and Beverage | $3,835.27 |
| Education | $154.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $12,920.13 | 2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (7881) US Und |
| Abiomed | $699.53 | 2024-2025 | Impella |
| W. L. Gore & Associates, INC. | $689.15 | 2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $664.77 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $500.74 | 2024-2025 | Avvigo Guidance System, Rotapro, General - Balloon Catheters |
| Medtronic, INC. | $237.93 | 2024-2025 | Resolute Onyx, In.Pact Admiral, Micra |
| Cardiva Medical, INC. | $143.05 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $142.86 | 2024-2025 | Repatha, Repatha |
| Stryker Corporation | $142.54 | 2025 | Clottriever Bold Catheter, Flowtriever, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.98 | 2024-2025 | Lifevest |
| Abbott Laboratories | $117.08 | 2025 | Esprit, Diamondback Peripheral |
| Vital Connect, INC | $107.60 | 2024-2025 | Vitalpatch Rtm |
| Novartis Pharmaceuticals Corporation | $107.55 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.54 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $81.75 | 2024-2025 | Camzyos, Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $66.69 | 2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $59.82 | 2025 | Uptravi |
| Novo Nordisk INC | $48.98 | 2025 | Wegovy |
| Biosense Webster, INC. | $40.68 | 2025 | Nuvision Ice Catheter |
| Bridgebio Pharma, INC. | $28.72 | 2025 | Attruby |
| Cvrx, INC. | $24.85 | 2025 | Barostim Neo System |
| Daiichi Sankyo INC. | $18.08 | 2025 | Injectafer |
| Penumbra, INC. | $16.43 | 2025 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Gabriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.